- Advertisement -

Special Campaign for Disposal of Pending Matters 2.0 in Department of Biotechnology – Odisha Diary

<!-- Special Campaign for Disposal of Pending Matters 2.0 in Department of Biotechnology – Odisha Diary

Avecho Biotechnology (ASX:AVE) pens deal for US recreational cannabis market – The Market Herald

Ricegrowers (ASX:SGLLV) renews supply arrangements – The Market Herald ...

New zebrafish xenograft platform could help screen for glioblastoma treatments

Scientists have created a new zebrafish xenograft platform to screen for novel treatments for an aggressive brain tumor called glioblastoma, according to a new...

New practical method of producing Airy beams could enhance ultrasound

Researchers at Washington University in St. Louis recently invented a technique for generating ultrasound waves that can self-bend, like a rainbow. Credit: Chen Lab/WashU Researchers at...

Restoring Balance: MiroBio’s New CEO Shepherds Precision Immunology Pipeline toward the...

MiroBio aims to advance therapies that address the immune imbalance that leads to autoimmune diseases. Those therapies—checkpoint agonist antibodies—are designed to precisely restore a...

The 9th ARDD: Longevity Biotechnology Is Gaining Prominence And Credibility In...

9th ARDD: Mindjourney AI-generated image depicting a convention of scientists at the University of ... Copenhagen Alex Zhavoronkov, PhD ...

From Images to Data

Read NowQuantitative spatial biology is coming of age. The desire to learn beyond the surface has always been present but now the ability to...

Aprea Expands Development of WEE1 Inhibitor After Seeing Early Clinical Activity...

Aprea Therapeutics is accelerating enrollment in its ongoing Phase I trial of its targeted cancer therapy APR-1051, one of the precision oncology drug developer’s...

From Images to Data

Read NowQuantitative spatial biology is coming of age. The desire to learn beyond the surface has always been present but now the ability to...

Aprea Expands Development of WEE1 Inhibitor After Seeing Early Clinical Activity Signs vs. Cancer

Aprea Therapeutics is accelerating enrollment in its ongoing Phase I trial of its targeted cancer therapy APR-1051, one of the precision oncology drug developer’s...

Myotis Bat Genomes Reveal How They Fight Viruses, Cancer, and Cellular Damage

Bats are among the most diverse mammalian species—second only to rodents—and are anomalies in the mammalian world: they fly, have long lifespans for their...

more new items

From Images to Data

Read NowQuantitative spatial biology is coming of age. The desire to learn beyond the surface has always been present but now the ability to...

Aprea Expands Development of WEE1 Inhibitor After Seeing Early Clinical Activity...

Aprea Therapeutics is accelerating enrollment in its ongoing Phase I trial of its targeted cancer therapy APR-1051, one of the precision oncology drug developer’s...

Myotis Bat Genomes Reveal How They Fight Viruses, Cancer, and Cellular...

Bats are among the most diverse mammalian species—second only to rodents—and are anomalies in the mammalian world: they fly, have long lifespans for their...